Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial

Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T19:25:04.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-13T11:52:30.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    No Change Detected
  6. Check
    38 days ago
    Change Detected
    Summary
    The study 'Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy (VENAZA-5S)' has been updated to a new version (v2.13.3) on 2024-12-09, replacing the previous version (v2.13.2) from 2023-08-08.
    Difference
    2%
    Check dated 2024-12-14T22:48:17.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T16:23:50.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    No new additions were noted, but a significant section of content related to data download options and study details has been removed.
    Difference
    14%
    Check dated 2024-11-23T04:42:47.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options in various file formats and a comprehensive selection of data fields for studies.
    Difference
    16%
    Check dated 2024-11-08T18:28:25.000Z thumbnail image

Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.